These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6100122)

  • 21. Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa.
    Ximenes J; Bassoi ON; de Menezes JP; Fry W
    J Int Med Res; 1976; 4(3):165-75. PubMed ID: 829072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
    Knothe H; Krcméry V; Mitsuhashi S
    Zentralbl Bakteriol A; 1980 Mar; 246(3):373-8. PubMed ID: 6775445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefoxitin: synergism with aminoglycosides in vitro.
    Une T; Osada Y; Ogawa H
    Arzneimittelforschung; 1981; 31(5):761-4. PubMed ID: 6791664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
    Saito M; Azuma K; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics].
    García Hierro P; Ponte Miramontes MC; Soriano García F
    Rev Clin Esp; 1980 Oct; 159(2):87-90. PubMed ID: 7209044
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
    Maslow MJ; Simberkoff MS; Rahal JJ
    J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bactericidal activity of amikacin and gentamicin.
    Shah RM; Heetderks G; Stille W
    Chemotherapy; 1977; 23(4):260-6. PubMed ID: 405182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J; Thomas M; Shanmugam J
    Indian J Pathol Microbiol; 1985 Apr; 28(2):115-9. PubMed ID: 3835114
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacokinetics of lividomycin, aminkacin and sisomicin in patients with chronic renal insufficiency].
    Leroy A; Oksenhendler G; Fillastre JP; Humbert G
    J Urol Nephrol (Paris); 1977 Sep; 83(9):738-41. PubMed ID: 243544
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
    Perea EJ; Clavijo E; Nogales MC; García Luque IG
    J Antimicrob Chemother; 1988 Aug; 22(2):175-83. PubMed ID: 3141342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of combinations of penicillin and aminoglycosides on Streptococcus faecalis: a comparative study of seven aminoglycoside antibiotics.
    Gutschik E; Jepsen OB; Mortensen I
    J Infect Dis; 1977 May; 135(5):832-6. PubMed ID: 67159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the combination action of sisomicin, gentamicin and cefmenoxime, ceftizoxime, cefoperazone, cefotetan against Serratia marcescens and Pseudomonas aeruginosa].
    Kubo M; Kato Y; Inamori Y
    Jpn J Antibiot; 1985 Dec; 38(12):3487-96. PubMed ID: 3938819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of Pseudomonas aeruginosa serotypes in bacteriologic specimens and their aminoglycoside resistance.
    Ullmann U; Schmülling RM
    Zentralbl Bakteriol A; 1980; 247(2):241-7. PubMed ID: 6775451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of Pseudomonas aeruginosa pneumonia with amikacin (author's transl)].
    Izawa T; Katakura K
    Jpn J Antibiot; 1979 Apr; 32(4):532-4. PubMed ID: 110964
    [No Abstract]   [Full Text] [Related]  

  • 35. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa with phage F 116 and AP 19, a new wildtype phage.
    Knothe H; Lebek G; Krcméry V; Seginková Z; Cervenka J; Antal M; Mitsuhashi S
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):506-10. PubMed ID: 6800151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative clinical pharmacology of amikacin and kanamycin in dairy calves.
    Ziv G
    Am J Vet Res; 1977 Mar; 38(3):337-40. PubMed ID: 403834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial synergism of piperacillin and gentamicin against pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus faecalis.
    Bach VT; Webb DW; Thadepalli H
    Chemotherapy; 1980; 26(1):21-7. PubMed ID: 6766372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.
    Yu PK; Washington JA
    Antimicrob Agents Chemother; 1973 Aug; 4(2):133-9. PubMed ID: 4208506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serotypes and minimal inhibitory concentration of different antibiotics in strains of PS. aeruginosa isolated from urologic patients (author's transl)].
    Fernández H; Zaror L; Otth L; Gutiérrez A; Tejero A; Wilson MG
    Rev Med Chil; 1978 Aug; 106(8):633-5. PubMed ID: 103157
    [No Abstract]   [Full Text] [Related]  

  • 40. UK-18892, a new aminoglycoside: an in vitro study.
    Wise R; Andrews JM
    Antimicrob Agents Chemother; 1978 Aug; 14(2):228-33. PubMed ID: 100050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.